NPB:NYSENorthpointe Bancshares, Inc. Analysis
Data as of 2026-05-28 - not real-time
$17.30
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Northpointe Bancshares (NPB) trades at $17.30, comfortably above its identified support of $16.87 and below the near‑term resistance of $17.94. The stock sits slightly under its 20‑day SMA (17.41) and 50‑day SMA (17.60), indicating a modest short‑term price lag, while the 200‑day SMA (17.42) is almost flat with the current level, suggesting a neutral longer‑term trend. Technical signals are mixed: the RSI of 46.6 points to a neutral momentum, but the MACD histogram is positive and the MACD line is above its signal, providing a bullish tilt. Volatility is elevated at 31% over the past 30 days and beta is 1.06, implying the stock moves slightly more than the market and could experience sharper swings.
Fundamentally, NPB appears attractively priced. A trailing P/E of 7.7 versus an industry average of 16.5 signals a substantial valuation discount, while the price‑to‑book of 1.01 aligns closely with book value. Revenue growth is robust at 28% YoY, operating margin stands at 46% and ROE at 15%, underscoring strong profitability. The dividend yield of 0.58% is modest but the payout ratio of just 4.5% makes the dividend highly sustainable. Analyst consensus targets around $21 imply roughly a 22% upside, and the market sentiment index shows “Extreme Greed,” indicating bullish investor appetite.
Fundamentally, NPB appears attractively priced. A trailing P/E of 7.7 versus an industry average of 16.5 signals a substantial valuation discount, while the price‑to‑book of 1.01 aligns closely with book value. Revenue growth is robust at 28% YoY, operating margin stands at 46% and ROE at 15%, underscoring strong profitability. The dividend yield of 0.58% is modest but the payout ratio of just 4.5% makes the dividend highly sustainable. Analyst consensus targets around $21 imply roughly a 22% upside, and the market sentiment index shows “Extreme Greed,” indicating bullish investor appetite.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with bullish MACD signal
- High short‑term volatility and modest volume
- Valuation discount provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high operating margins
- Undervalued multiples relative to industry peers
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Solid ROE and consistent profitability
- Long‑run upside potential toward analyst price targets
- Resilient balance sheet despite elevated debt levels
Key Metrics & Analysis
Financial Health
Revenue Growth27.90%
Profit Margin35.11%
P/E Ratio7.7
ROE15.01%
ROA1.33%
P/B Ratio1.0
Op. Cash Flow$27.6M
Industry P/E16.5
Technical Analysis
TrendNeutral
RSI46.6
Support$16.87
Resistance$17.94
MA 20$17.41
MA 50$17.60
MA 200$17.42
MACDBullish
VolumeStable
Fear & Greed Index92.91
Valuation
Target Price$21.08
Upside/Downside21.87%
GradeUndervalued
TypeBlend
Dividend Yield0.58%
Risk Assessment
Beta1.06
Volatility31.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.